IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Par Drugs and Chemicals IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Vadodara and caters to Pharmaceutical sector. Pantomath Capital Advisors is the merchant banker of Par Drugs and Chemicals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th March 2019.
Par Drugs and Chemicals IPO posted revenues of ₹ 46.41 crores and PAT of ₹ 2.42 crores in FY19 on annualised basis.
Revenue:
₹ 46.32 Cr.
EBITDA Margin:
17.88
% 
Net Worth: ₹ 29.11 Cr.
Market Capitalisation:
[●]
P/E:
13.00 times
P/BV: [●]
EV/EBITDA: [●]
Financial results of Par Drugs and Chemicals IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Mar-19 | FY18 | FY17 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 51.35 | 53.93 | 56.04 | ||
| Net Worth | 29.11 | 20.69 | 19.20 | ||
| Total Debt | 11.58 | 23.12 | 24.80 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
46.32
46.32 |
42.37 | 48.76 | ||
EBITDA
EBITDA on annualised basis |
8.28
8.28 |
8.02 | 8.50 | ||
PAT
PAT on annualised basis |
2.41
2.41 |
1.49 | 1.84 | ||
Par Drugs and Chemicals IPO PAT Margin is 5.20 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Par Drugs and Chemicals IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Mar-19 | FY18 | FY17 |
|---|---|---|---|
| EBITDA Margin (%) | 17.88 | 18.93 | 17.43 |
| PAT Margin (%) | 5.20 | 3.52 | 3.77 |
| EPS (₹) | 5.40 | 5.54 | 6.84 |
| ROE (%) | 8.28 | 7.20 | 9.58 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 4.69 | 2.76 | 3.28 |
| Debt to Equity | 0.40 | 1.12 | 1.29 |
The market Capitalisation of Par Drugs and Chemicals IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Par Drugs and Chemicals IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Par Drugs and Chemicals IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Par Drugs and Chemicals IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Par Drugs and Chemicals IPO has a Price-to-Earnings (PE) ratio of 13.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Par Drugs and Chemicals IPO reported revenue of ₹ 46.41 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Par Drugs and Chemicals IPO provide insights into sales growth, market demand, and business scalability.
Par Drugs and Chemicals recorded an EBITDA of ₹ 8.28 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Par Drugs and Chemicals Profit After Tax (PAT) is ₹ 2.41 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 46.32 Cr.
EBITDA Margin:
17.88
%
Net Worth: ₹ 29.11 Cr.
Market Capitalisation:
[●]
P/E:
13.00 times
P/BV: [●]
EV/EBITDA: [●]
Par Drugs and Chemicals operates in Pharmaceutical and . The Issue is listed on NSE EMERGE in May, 2019. Par Drugs and Chemicals IPO size was 8.53 with Issue price of 51.00 .
Merchant Banker(s) of Par Drugs and Chemicals IPO: Pantomath Capital Advisors Private Limited
Par Drugs and Chemicals IPO subscription was 5.74 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Par Drugs and Chemicals IPO listed at a listing price of 51.45 against the offer price of 51.00.
The current market price of Par Drugs and Chemicals is 99.41.
Why Us?
